Alliancebernstein L.P. United Therapeutics Corp Transaction History
Alliancebernstein L.P.
- $261 Billion
- Q1 2025
A detailed history of Alliancebernstein L.P. transactions in United Therapeutics Corp stock. As of the latest transaction made, Alliancebernstein L.P. holds 454,983 shares of UTHR stock, worth $145 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
454,983
Previous 709,043
35.83%
Holding current value
$145 Million
Previous $250 Million
43.94%
% of portfolio
0.05%
Previous 0.09%
Shares
31 transactions
Others Institutions Holding UTHR
# of Institutions
733Shares Held
43.6MCall Options Held
124KPut Options Held
122K-
Black Rock Inc. New York, NY5.47MShares$1.74 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.46MShares$1.42 Billion0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.68MShares$853 Million13.34% of portfolio
-
State Street Corp Boston, MA2.23MShares$711 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.11MShares$672 Million1.04% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $14.5B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...